-+ 0.00%
-+ 0.00%
-+ 0.00%

Edgewise Therapeutics Reports Positive Interim Safety Results for EDG-7500 in Phase 2 CIRRUS-HCM Trial

路透·12/24/2025 13:00:27

登录查看新闻详情